financetom
Business
financetom
/
Business
/
LTC Properties' Q3 Adjusted Funds From Operation, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LTC Properties' Q3 Adjusted Funds From Operation, Revenue Increase
Nov 3, 2024 1:24 PM

04:26 AM EDT, 10/29/2024 (MT Newswires) -- LTC Properties ( LTC ) reported Q3 adjusted funds from operations late Monday of $0.68 per diluted share, up from $0.65 a year earlier.

Analysts polled by Capital IQ expected $0.68.

Revenue for the quarter ended Sept. 30 was $55.8 million, compared with $49.3 million a year earlier.

Analysts surveyed by Capital IQ expected $46 million.

Price: 36.66, Change: +0.72, Percent Change: +2.00

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Constellation Brands Beats On Q2 Earnings, Beer Business Achieved Solid Mid-Single-Digit Sales Growth
Constellation Brands Beats On Q2 Earnings, Beer Business Achieved Solid Mid-Single-Digit Sales Growth
Oct 3, 2024
Constellation Brands, Inc. ( STZ ) shares are trading slightly lower on Thursday. The company reported second-quarter adjusted earnings per share of $4.32, beating the analyst consensus of $4.08. Quarterly revenues of $2.92 billion beat the street view of $2.90 billion. The company reported a loss per share of $6.59, including a non-cash goodwill impairment loss for the Wine and...
Aldeyra Therapeutics Resubmits New Drug Application for Dry Eye Disease Treatment Candidate
Aldeyra Therapeutics Resubmits New Drug Application for Dry Eye Disease Treatment Candidate
Oct 3, 2024
09:35 AM EDT, 10/03/2024 (MT Newswires) -- Aldeyra Therapeutics ( ALDX ) said Thursday it has resubmitted a new drug application to the US Food and Drug Administration for topical ocular reproxalap, which is being developed as a treatment for signs and symptoms of dry eye disease. Included in the resubmission were previously disclosed results from a completed trial requested...
TotalEnergies CEO Warns of Potential Decline in UK Investments Amid Looming Tax Increase
TotalEnergies CEO Warns of Potential Decline in UK Investments Amid Looming Tax Increase
Oct 3, 2024
09:36 AM EDT, 10/03/2024 (MT Newswires) -- TotalEnergies (TTE) chief executive officer Patrick Pouyanne said Wednesday that the French energy giant will be selective with capital expenditures in the UK and may restructure its North Sea operations if the country imposes a higher windfall tax on oil and gas producers. The UK government announced plans in July to increase its...
Hims & Hers Health Stock Is Tumbling Thursday: Here's Why
Hims & Hers Health Stock Is Tumbling Thursday: Here's Why
Oct 3, 2024
Hims & Hers Health Inc ( HIMS ) shares are trading lower Thursday in possible sympathy with Eli Lilly And Co’s , after the U.S. Food and Drug Administration removed it from the weight-loss and diabetes drugs shortage list. What Happened: The FDA said in a statement late Wednesday that Eli Lilly's ( LLY ) supply of Mounjaro, which is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved